These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3262389)

  • 1. Hemophilia B Durham: a mutation in the first EGF-like domain of factor IX that is characterized by polymerase chain reaction.
    Denton PH; Fowlkes DM; Lord ST; Reisner HM
    Blood; 1988 Oct; 72(4):1407-11. PubMed ID: 3262389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor IXHollywood: substitution of Pro55 by Ala in the first epidermal growth factor-like domain.
    Spitzer SG; Kuppuswamy MN; Saini R; Kasper CK; Birktoft JJ; Bajaj SP
    Blood; 1990 Oct; 76(8):1530-7. PubMed ID: 2169923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine hemophilia B resulting from a point mutation with unusual consequences.
    Evans JP; Brinkhous KM; Brayer GD; Reisner HM; High KA
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10095-9. PubMed ID: 2481310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Gly --> Ser change causes defective folding in vitro of calcium-binding epidermal growth factor-like domains from factor IX and fibrillin-1.
    Whiteman P; Downing AK; Smallridge R; Winship PR; Handford PA
    J Biol Chem; 1998 Apr; 273(14):7807-13. PubMed ID: 9525872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A codon 338 nonsense mutation in the factor IX gene in unrelated hemophilia B patients: factor IX338 New York.
    Driscoll MC; Bouhassira E; Aledort LM
    Blood; 1989 Aug; 74(2):737-42. PubMed ID: 2752145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia B.
    Lozier JN; Monroe DM; Stanfield-Oakley S; Lin SW; Smith KJ; Roberts HR; High KA
    Blood; 1990 Mar; 75(5):1097-104. PubMed ID: 2306516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA sequence analysis of three inhibitor-positive hemophilia B patients without gross gene deletion: identification of four novel mutations in factor IX gene.
    Matsushita T; Tanimoto M; Yamamoto K; Sugiura I; Hamaguchi M; Takamatsu J; Kamiya T; Saito H
    J Lab Clin Med; 1990 Oct; 116(4):492-7. PubMed ID: 2212858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor IXBasel: a Swiss family with severe haemophilia B having a point mutation in EGF type B domain.
    Alkan M; Rodriguez Ponte M; Malik NJ; Hofmann S; Bösch-Al Jadooa N; Müller H; Bühler EM
    Nucleic Acids Res; 1991 Jan; 19(2):409. PubMed ID: 2014182
    [No Abstract]   [Full Text] [Related]  

  • 9. A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B.
    Vidaud M; Chabret C; Gazengel C; Grunebaum L; Cazenave JP; Goossens M
    Blood; 1986 Oct; 68(4):961-3. PubMed ID: 2875754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three point mutations in the factor IX genes of five hemophilia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteins.
    Chen SH; Thompson AR; Zhang M; Scott CR
    J Clin Invest; 1989 Jul; 84(1):113-8. PubMed ID: 2472424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three distinct point mutations in the factor IX gene of three Japanese CRM+ hemophilia B patients (factor IX BMNagoya 2, factor IX Nagoya 3 and 4).
    Hamaguchi M; Matsushita T; Tanimoto M; Takahashi I; Yamamoto K; Sugiura I; Takamatsu J; Ogata K; Kamiya T; Saito H
    Thromb Haemost; 1991 May; 65(5):514-20. PubMed ID: 1871712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two mutations of the factor IX gene including a donor splice consensus deletion and a point mutation in a Dutch patient with severe hemophilia B.
    Poort SR; Briët E; Bertina RM; Reitsma PH
    Thromb Haemost; 1990 Nov; 64(3):379-84. PubMed ID: 2096489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A moderate form of hemophilia B is caused by a novel mutation in the protease domain of factor IXVancouver.
    Geddes VA; Le Bonniec BF; Louie GV; Brayer GD; Thompson AR; MacGillivray RT
    J Biol Chem; 1989 Mar; 264(8):4689-97. PubMed ID: 2494175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophilia B caused by five different nondeletion mutations in the protease domain of factor IX.
    Ludwig M; Sabharwal AK; Brackmann HH; Olek K; Smith KJ; Birktoft JJ; Bajaj SP
    Blood; 1992 Mar; 79(5):1225-32. PubMed ID: 1346975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three novel and one C31133T (Arg-338-->Stop) mutations of antihemophilic factor IX gene detected in Taiwan.
    Young JH; Wang JC; Lin YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Apr; 57(4):241-6. PubMed ID: 8705874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A factor IX mutation, verified by direct genomic sequencing, causes haemophilia B by a novel mechanism.
    Tsang TC; Bentley DR; Mibashan RS; Giannelli F
    EMBO J; 1988 Oct; 7(10):3009-15. PubMed ID: 3181127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B].
    Seita I; Shinozawa K; Otaki M; Fujita S; Suzuki T; Amano K; Inaba H; Fukutake K
    Rinsho Byori; 2009 May; 57(5):417-24. PubMed ID: 19522246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.
    Schach BG; Yoshitake S; Davie EW
    J Clin Invest; 1987 Oct; 80(4):1023-8. PubMed ID: 2821070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Dutch pedigree with mild hemophilia B with a missense mutation in the first EGF domain (factor IXOud en Nieuw Gastel).
    Poort SR; Briët E; Bertina RM; Reitsma PH
    Nucleic Acids Res; 1989 Jul; 17(14):5869. PubMed ID: 2762170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.